Riskpilot← Back to searchSign inGet full accessFAL MED AB
ABActiveOrg 5568340326Fiskareliden 1 BGeneral medical practice activities · NACE 8621Est. 20103 employees
Revenue 2024
SEK 3,7M
+30% vs 2023
EBITDA margin
25.9%
+27% vs 2023
Equity ratio
52.3%
Financial strength
Net profit 2024
SEK 751K
+26% vs 2023
| Revenue | SEK 3,7M | +30% |
| EBITDA | SEK 967K | +27% |
| Net profit | SEK 751K | +26% |
| Total assets | SEK 2M | +38% |
| Equity | SEK 1M | +51% |
| Employees | 3 | — |
Legal name
FAL MED AB
Org number
5568340326
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 december 2010
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Khattab, Omar Adel Abdullah
Company purpose
Bedriver Bild och funktion medicin. Företaget ska bedriva verksamhet inom medicinisk radiologi, innefattande radiologisk konsultation, bildtolkning av olika modaliteter såsom röntgen, datortomografi (CT), magnetresonanstomografi (MR), ultraljud och genomlysning. Verksamheten omfattar även utförande av diagnostiska undersökningar, handledning och utbildning av läkare under specialistutbildning samt deltagande i och ledning av radiologiska ronder vid olika kliniker. Företaget kan även bedriva relaterad verksamhet inom medicinsk utbildning, forskning, utveckling och rådgivning samt därmed förenlig verksamhet.
Address
Fiskareliden 1 B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 089 | 1 349 | 2 265 | 2 864 | 3 734 |
| Staff expenses | — | — | −1 144 | −1 351 | −1 888 |
| EBITDA | 506 | 195 | 209 | 763 | 967 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 506 | 195 | 209 | 763 | 967 |
| Net financials | — | — | −1 | 1 | 4 |
| Profit before tax | 506 | 195 | 207 | 763 | 970 |
| Tax | −110 | −46 | −60 | −166 | −219 |
| Net profit | 396 | 149 | 147 | 597 | 751 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 648 | 759 | 779 | 1 435 | 1 978 |
| Equity | 466 | 465 | 386 | 683 | 1 035 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 181 | 294 | 393 | 752 | 943 |
| Total debt | 181 | 294 | 393 | 752 | 943 |
EBITDA margin
25.9%
This company
15.8%
Market median
+64% vs market
20202024
Equity ratio
52.3%
This company
38.2%
Market median
+37% vs market
20202024
Return on equity
72.6%
This company
18.4%
Market median
+295% vs market
20202024
Net profit margin
20.1%
This company
8.1%
Market median
+148% vs market
20202024
Asset turnover
1.89×
This company
1.12×
Market median
+69% vs market
20202024
Debt / equity
0.91×
This company
0.62×
Market median
+47% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FAL MED AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sura Al-Rawi | Board of Directors | 0 companies |
| Omar Adel Abdullah Khattab | Chairman | 0 companies |
| Homam Ahmed Adel | Deputy Board Member | 0 companies |